Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics
Rigel Pharmaceuticals, Inc. (RIGL)
Today's Latest Price: $1.86 USD
0.10 (-5.10%)
Updated Jul 9 2:17pm
Add RIGL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
RIGL Stock Summary
- For RIGL, its debt to operating expenses ratio is greater than that reported by only 21.8% of US equities we're observing.
- Over the past twelve months, RIGL has reported earnings growth of -56.7%, putting it ahead of 25.57% of US stocks in our set.
- Revenue growth over the past 12 months for Rigel Pharmaceuticals Inc comes in at 79.27%, a number that bests 93.02% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Rigel Pharmaceuticals Inc are MRIN, SWAV, GEOS, EMKR, and AKER.
- RIGL's SEC filings can be seen here. And to visit Rigel Pharmaceuticals Inc's official web site, go to www.rigel.com.
RIGL Daily Price Range
RIGL 52-Week Price Range
RIGL Stock Price Chart Technical Analysis Charts
RIGL Price/Volume Stats
| Current price | $1.86 | 52-week high | $3.10 |
| Prev. close | $1.96 | 52-week low | $1.23 |
| Day low | $1.86 | Volume | 2,292,036 |
| Day high | $2.13 | Avg. volume | 1,672,330 |
| 50-day MA | $1.88 | Dividend yield | N/A |
| 200-day MA | $1.99 | Market Cap | 313.54M |
Rigel Pharmaceuticals, Inc. (RIGL) Company Bio
Rigel Pharmaceuticals, Inc. engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. The company was founded in 1996 and is based in South San Francisco, California.
Loading social stream, please wait...